| MeSH term | MeSH ID | Detail |
|---|---|---|
| Iron Overload | D019190 | 11 associated lipids |
| Pregnancy Complications, Hematologic | D011250 | 11 associated lipids |
| Hepatitis | D006505 | 11 associated lipids |
| Myocardial Ischemia | D017202 | 11 associated lipids |
| Hearing Disorders | D006311 | 10 associated lipids |
| Myocardial Stunning | D017682 | 10 associated lipids |
| Renal Insufficiency, Chronic | D051436 | 9 associated lipids |
| Ascorbic Acid Deficiency | D001206 | 9 associated lipids |
| Leprosy | D007918 | 8 associated lipids |
| Jaundice, Neonatal | D007567 | 7 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Liu Y et al. | New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. | 2004 | J. Am. Chem. Soc. | pmid:15198572 |
| Zager RA et al. | Parenteral iron nephrotoxicity: potential mechanisms and consequences. | 2004 | Kidney Int. | pmid:15200421 |
| Sengoelge G et al. | Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. | 2004 | Kidney Int. | pmid:15200437 |
| Lakatos A et al. | AlIII ion complexes of saccharic acid and mucic acid: a solution and solid-state study. | 2004 | Chemistry | pmid:15007818 |
| Folkert VW | Safety of high doses of non-dextran irons. | 2003 May-Jun | Semin Dial | pmid:12753696 |
| Okada DR et al. | Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. | 2003 Mar-Apr | J Nucl Cardiol | pmid:12673182 |
| Mukhin IV and Nikolenko VIu | [Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]. | 2003 Jul-Aug | Eksp Klin Farmakol | pmid:14558349 |
| Souqiyyeh MZ and Shaheen FA | Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209438 |
| Zolezzi M | Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209437 |
| Flotats A and Carrió I | Non-invasive in vivo imaging of myocardial apoptosis and necrosis. | 2003 | Eur. J. Nucl. Med. Mol. Imaging | pmid:12638039 |
| Silverberg DS et al. | Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. | 2003 | Isr. Med. Assoc. J. | pmid:12811950 |
| Singh J and Gupta KP | Calcium glucarate prevents tumor formation in mouse skin. | 2003 | Biomed. Environ. Sci. | pmid:12747003 |
| Yang W et al. | The first fluorescent sensor for D-glucarate based on the cooperative action of boronic acid and guanidinium groups. | 2003 | Chem. Commun. (Camb.) | pmid:12703826 |
| Edwards JH | Clinical review of the newer intravenous iron therapy options. | 2003 | Nephrol Nurs J | pmid:12674953 |
| Ballinger JR et al. | Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. | 2003 | Nucl Med Commun | pmid:12717079 |
| Chuang CL et al. | Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. | 2003 | Nephrol. Dial. Transplant. | pmid:12543894 |
| Folkert VW et al. | Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. | 2003 | Am. J. Kidney Dis. | pmid:12612989 |
| Beshara S et al. | Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. | 2003 | Br. J. Haematol. | pmid:12614222 |
| Apostoli P et al. | Relationship between PCBs in blood and D-glucaric acid in urine. | 2003 | Toxicol. Lett. | pmid:12919720 |
| Deicher R et al. | High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. | 2003 | Kidney Int. | pmid:12846772 |
| Fishbane S | Safety issues with iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:12666081 |
| Séronie-Vivien S et al. | Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report. | 2003 | Med. Oncol. | pmid:14514981 |
| Folkert VW | Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. | 2003 | Nephrol Nurs J | pmid:14621635 |
| Breborowicz M et al. | Effect of iron sucrose on human peritoneal mesothelial cells. | 2003 | Eur. J. Clin. Invest. | pmid:14636286 |
| Tutor-Crespo MJ et al. | Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. | 2003 | Epilepsy Res. | pmid:14642999 |
| Blaustein DA et al. | The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. | 2003 | Kidney Int. Suppl. | pmid:14531777 |
| Colfer M | Achieving optimal patient outcomes with intravenous iron. | 2003 | Nephrol Nurs J | pmid:14533524 |
| Geisser P | Reactivity of iron compounds. | 2003 | Am. J. Kidney Dis. | pmid:14582056 |
| Danielson BG and Beshara S | Pharmacokinetics and utilization of iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:14582057 |
| Schröder CH | The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. | 2003 | Pediatr. Nephrol. | pmid:12750985 |
| Hanausek M et al. | Detoxifying cancer causing agents to prevent cancer. | 2003 | Integr Cancer Ther | pmid:15035900 |
| Tutor-Crespo MJ et al. | [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. | 2002 Oct 16-31 | Rev Neurol | pmid:12402220 |
| Breymann C | Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. | 2002 Nov-Dec | Blood Cells Mol. Dis. | pmid:12547241 |
| Dittrich E et al. | Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. | 2002 Jan-Feb | Perit Dial Int | pmid:11929146 |
| Shaheen FA et al. | Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. | 2002 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:17660651 |
| Bayoumeu F et al. | [Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation]. | 2002 | Ann Fr Anesth Reanim | pmid:11878118 |
| Arteaga de Murphy C et al. | 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. | 2002 | Int J Pharm | pmid:11897407 |
| Calcium-D-glucarate. | 2002 | Altern Med Rev | pmid:12197785 | |
| Zager RA et al. | Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. | 2002 | Am. J. Kidney Dis. | pmid:12087566 |
| Michaud L et al. | Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. | 2002 | Clin Nutr | pmid:12381338 |
| Oldham FB | Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? | 2002 | Am. J. Kidney Dis. | pmid:12407662 |
| Silverberg DS et al. | The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. | 2002 | Clin. Nephrol. | pmid:12227725 |
| Wali A et al. | Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. | 2002 | J Pak Med Assoc | pmid:12532571 |
| Yee J and Besarab A | Iron sucrose: the oldest iron therapy becomes new. | 2002 | Am. J. Kidney Dis. | pmid:12460028 |
| Bauer S et al. | Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers. | 2002 | Eur. J. Clin. Pharmacol. | pmid:12483450 |
| Hosoya S et al. | Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. | 2002 | FEMS Microbiol. Lett. | pmid:12044674 |
| Boase S and Miners JO | In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. | 2002 | Br J Clin Pharmacol | pmid:12445028 |
| Rooyakkers TM et al. | Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. | 2002 | Eur. J. Clin. Invest. | pmid:11886426 |
| Kooistra MP et al. | Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. | 2002 | Eur. J. Clin. Invest. | pmid:11886430 |
| Bayoumeu F et al. | Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. | 2002 | Am. J. Obstet. Gynecol. | pmid:11904617 |